{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-011088","form_type":"8-K","ticker":"MXCT","cik":"0001287098","company_name":"MAXCYTE, INC.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.474444+00:00","generated_at":"2026-05-31T12:10:16.091438+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MaxCyte Q2 revenue up 15% to $10.4M; core revenue down 9% to $7.6M; SPL revenue jumps 279%","bullets":["Total revenue $10.4M (+15% YoY); core business revenue $7.6M (-9% YoY); SPL program-related revenue $2.9M (+279% YoY).","Net loss narrowed to $9.4M from $10.5M in Q2 2023; EBITDA loss $10.9M vs $12.0M.","Signed five new SPLs YTD including Legend Biotech (May) and Be Biopharma (Mar); total SPL partners now 28.","Ended Q2 with $199.8M cash; now expects FY2024 ending cash at least $180M, up from prior $175M guidance.","Raised FY2024 SPL revenue guidance to ~$6M; core business revenue guidance reaffirmed flat to 5% growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-011088","json":"https://secwatch.observer/filing/0001558370-24-011088.json","markdown":"https://secwatch.observer/filing/0001558370-24-011088.md","text":"https://secwatch.observer/filing/0001558370-24-011088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1287098/000155837024011088/0001558370-24-011088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1287098/000155837024011088/mxct-20240806x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:10:16.091438+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}